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Abstract. 
 
The dynamic rearrangement of cell–cell 
junctions such as tight junctions and adherens junctions 
is a critical step in various cellular processes, including 
establishment of epithelial cell polarity and develop-
mental patterning. Tight junctions are mediated by 
molecules such as occludin and its associated ZO-1 and 
ZO-2, and adherens junctions are mediated by adhe-
sion molecules such as cadherin and its associated 
catenins. The transformation of epithelial cells by acti-
vated Ras results in the perturbation of cell–cell con-
tacts. We previously identified the ALL-1 fusion part-
ner from chromosome 6 (AF-6) as a Ras target. AF-6 
has the PDZ domain, which is thought to localize AF-6 
at the specialized sites of plasma membranes such as 
cell–cell contact sites. We investigated roles of Ras and 
AF-6 in the regulation of cell–cell contacts and found 
that AF-6 accumulated at the cell–cell contact sites of 
polarized MDCKII epithelial cells and had a distribu-
tion similar to that of ZO-1 but somewhat different 
from those of catenins. Immunoelectron microscopy re-
vealed a close association between AF-6 and ZO-1 at 
the tight junctions of MDCKII cells. Native and recom-
binant AF-6 interacted with ZO-1 in vitro. ZO-1 inter-
acted with the Ras-binding domain of AF-6, and this in-
teraction was inhibited by activated Ras. AF-6 
accumulated with ZO-1 at the cell–cell contact sites in 
cells lacking tight junctions such as Rat1 fibroblasts and 
PC12 rat pheochromocytoma cells. The overexpression 
of activated Ras in Rat1 cells resulted in the perturba-
tion of cell–cell contacts, followed by a decrease of the 
accumulation of AF-6 and ZO-1 at the cell surface. 
These results indicate that AF-6 serves as one of the pe-
ripheral components of tight junctions in epithelial cells 
and cell–cell adhesions in nonepithelial cells, and that 
AF-6 may participate in the regulation of cell–cell con-
tacts, including tight junctions, via direct interaction 
with ZO-1 downstream of Ras.
 
R
 
as
 
 (Ha-Ras, Ki-Ras, N-Ras) is a signal-transducing,
guanine nucleotide-binding protein for various mem-
brane receptors including tyrosine kinase recep-
tors. Ras participates in the regulation of cell proliferation,
differentiation, and morphology (for reviews see Satoh et al.,
1992; McCormick, 1994). Activated ras oncogenes have been
identified in various forms of human cancers including ep-
ithelial carcinomas of the lung, colon, and pancreas (Bar-
bacid, 1987). These cancer cells, as well as those that have
been experimentally transformed by the activated ras
gene, exhibit morphological changes and alterations of cell
adhesions. Ras is thought to affect cell adhesions and cy-
toskeletons via alterations of the signaling pathways down-
stream of Ras. Ras has GDP-bound inactive and GTP-
bound active forms, the latter of which interact with targets
(Marshall, 1995
 
b
 
). The Raf kinase family, consisting of
c-Raf-1 (for reviews see Blenis, 1993; Daum et al., 1994),
A-Raf (Vojtek et al., 1993), and B-Raf (Catling et al., 1994;
Jaiswal et al., 1994; Moodie et al., 1994; Yamamori et al.,
1995), is one of the direct targets for Ras. The activated
Raf phosphorylates mitogen-activated protein (MAP)
 
1
 
 ki-
nase kinase and activates it. Consequently the activated
MAP kinase kinase activates MAP kinase, leading to the
expression of certain genes such as c-
 
fos
 
 (for reviews see
Cano and Mahadevan, 1995; Marshall, 1995
 
a
 
). Several
molecules interacting with activated Ras in addition to Raf
have been identified as Ras targets in mammals. These in-
clude phosphatidylinositol-3-OH kinase (Rodriguez-Vici-
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ana et al., 1994), Ral guanine nucleotide dissociation stim-
ulator (Kikuchi et al., 1994; Spaargaren and Bischoff, 1994),
and Rin1 (Han and Colicelli, 1995). We previously identi-
fied the ALL-1 fusion partner from chromosome 6 (AF-6)
as a novel Ras target (Kuriyama et al., 1996). AF-6 was iden-
tified as the fusion partner of the acute lymphoblastic leu-
kemia-1 (ALL-1) protein (Prasad et al., 1993). The ALL-1/
AF-6 chimeric protein is the critical product of the t(6;11)
abnormality associated with some human leukemia. AF-6
has a PDZ (GLGF/DHR) domain that is found in a num-
ber of other proteins, including postsynaptic density pro-
tein 95 (PSD-95) (Cho et al., 1992), 
 
Drosophila
 
 discs-large
tumor suppressor gene product (Dlg) (Woods and Bryant,
1991), and a tight junction-associated protein, ZO-1 (Itoh
et al., 1993; Willott et al., 1993). The PDZ domain is thought
to localize these proteins at the specialized sites of cell–cell
contact by forming a complex with specific proteins such as
the NMDA receptor and the K
 
1
 
 channel (Kim et al., 1995;
Kornau et al., 1995).
The dynamic rearrangement of cell–cell contacts is a criti-
cal step in various cellular processes including the establish-
ment of epithelial cell polarity and developmental pattern-
ing (for review see Gumbiner, 1996). Cell–cell junctions
are categorized into at least three groups: tight, adherens,
and gap junctions (for reviews see Farquhar and Palade,
1963; Tsukita et al., 1993). Tight junctions, the most apical
components of the junctional complex, form a diffusion
barrier that regulates the flux of ions and hydrophilic mol-
ecules through the paracellular pathway (for reviews see
Diamond, 1977; Gumbiner, 1987). Tight junctions are me-
diated by molecules such as occludin and its associated
ZO-1 and -2 (Anderson et al., 1988; Furuse et al., 1994; for
review see Anderson, 1996). Adherens junctions are char-
acterized by a well-developed plaque structure in which
actin filaments are densely associated. Adherens junctions
are mediated by adhesion molecules such as cadherin and
its associated catenins (for reviews see Takeichi, 1990; Hüls-
ken et al., 1994). These junctions undergo dynamic remod-
eling when cells move or enter the mitotic phase. Al-
though these junctions are suspected to be regulated by
certain intracellular signaling pathways, little is known at
present about how they are actually regulated. Accumulat-
ing evidence suggests that small GTPases Ras and Rho
family members including Rho, Rac, and Cdc42 partici-
pate in the regulation of cell adhesions (for review see
Hall, 1994).
In light of these observations, we investigated roles of
Ras and its target AF-6 in the regulation of cell–cell con-
tacts. We found that AF-6 accumulated at cell–cell contact
sites of MDCKII epithelial cells and had a distribution
similar to that of ZO-1. AF-6 interacted with ZO-1, and
this interaction was inhibited by activated Ras.
 
Materials and Methods
 
Materials and Chemicals
 
MDCKII cell, mouse anti–ZO-1 antibody and rat anti–
 
a
 
-catenin antibody
were kindly provided by Dr. S. Tsukita (Kyoto University, Kyoto, Japan;
Itoh et al., 1991). Rat1 and Rat1 RasVal A1 cells were kindly provided by
Dr. Y. Kaziro (Tokyo Institute of Technology, Yokohama, Japan). Rabbit
polyclonal antibody against AF-6 (1,130–1,612 amino acids) was gener-
ated as described previously (Harlow and Lane, 1988). FITC-conjugated
anti–rabbit IgG, Texas red-conjugated anti–mouse IgG, and [
 
35
 
S]methion-
ine were purchased from Amersham Intl. (Arlington Heights, IL). The ex-
pression plasmids of glutathione-
 
S
 
-transferase (GST)-mouse ZO-1 (1–862
amino acids), GST-mouse ZO-2 (1–400 amino acids), GST-mouse occlu-
din (264–521 amino acids), GST–E-cadherin cytoplasmic domain, GST-
mouse 
 
a
 
-catenin and GST–
 
b
 
-catenin were kindly provided by Dr. S. Tsukita
(Kyoto University). GST fusion proteins were expressed in 
 
Escherichia
coli
 
 BL21(DE3) and purified according to the manufacturer’s instructions.
Bovine brain membrane fraction was prepared as described previously
(Kuriyama et al., 1996) and preabsorbed to remove the native GST with
glutathione Sepharose 4B (Pharmacia Biotech Inc., Grand Island, NY).
To obtain recombinant HA-AF-6 (36–1,608 amino acids), the baculovirus
expression plasmid pAcYM1-HA-AF-6 (36–1,608 amino acids) was con-
structed as follows. The cDNA fragment encoding AF-6 (36–1,608 amino
acids) was amplified by polymerase chain reaction from the full length
AF-6 cDNA in pBluescript and was subcloned into the KpnI site of
pAcYM1-HA (Matsuura et al., 1987). Sf9 cells infected with baculovirus
carrying the cDNA of HA-AF-6 (36–1,608 amino acids) were suspended
in buffer A (20 mM Tris/HCl at pH 7.5, 1 mM EDTA, 1 mM DTT, 5 mM
MgCl
 
2
 
, 10% sucrose, 10 
 
m
 
M [
 
p
 
-amidino-phenyl] methanesulfonyl fluoride,
10 
 
m
 
g/ml leupeptin). The suspension was sonicated and centrifuged at
100,000 
 
g
 
 for 60 min at 4
 
8
 
C. The supernatant was used for affinity column
chromatography. Other materials and chemicals were obtained from com-
mercial sources.
 
Cell Culture
 
MDCKII and Rat1 cells were grown in DME containing 10% FCS, peni-
cillin, and streptomycin in an air-5% CO
 
2
 
 atmosphere at constant humid-
ity. Rat1 RasVal A1 cells were grown in DME containing 10% FCS, 1 mg/ml
Geneticin, 0.4 mg/ml Hygromycin B, penicillin, and streptomycin in an
air-5% CO
 
2
 
 atmosphere at constant humidity. PC12 cells were grown in
DME containing 10% FCS, 5% horse serum, penicillin, and streptomycin
in an air-5% CO
 
2
 
 atmosphere at constant humidity. For Ca
 
2
 
1
 
 switch assay,
subconfluent MDCKII cells were grown in normal growth media and
transferred to low Ca
 
2
 
1
 
 medium (growth media containing 4 mM EGTA)
for 6 h and were then transferred back to the normal Ca
 
2
 
1
 
 medium. To ex-
amine the distribution of AF-6 in Rat1 RasVal A1 cells, Rat1 RasVal A1
cells plated on 13-mm-round glass coverslips were incubated either with
or without 5 mM isopropyl–
 
b
 
-
 
d
 
-thiogalactoside (IPTG) for 24 h.
 
Immunofluorescence and Laser Scanning
Confocal Microscopy
 
MDCKII, PC12, Rat1, and Rat1 RasVal A1 cells plated on 13-mm-round
glass coverslips were fixed in 4% paraformaldehyde in PBS for 10 min and
permeabilized with 0.2% Triton X-100 in PBS for 10 min. The fixed cells
were incubated with primary antibodies for 1 h at room temperature and
washed three times for 10 min with PBS. After the first labeling, the cells
were incubated for 1 h with secondary antibodies and washed three times
for 10 min with PBS. The distributions of AF-6, ZO-1, and 
 
a
 
-catenin were
examined with a laser scanning confocal microscope (Carl Zeiss, Inc.,
Thornwood, NY) equipped with an argon laser and a helium-neon laser
for double fluorescence at 488 and 543 nm (emission filter; BP510-525 and
LP590). 20 horizontal confocal sections were obtained for MDCKII cells
and used to generate three-dimensional images.
 
Immunoelectron Microscopy
 
Immunoelectron microscopy was carried out as described previously
(Burry et al., 1992; Jongens et al., 1994; Uchida et al., 1996). MDCKII cells
were cultured on tissue culture-treated polycarbonate filters (Transwell;
Coaster Corp., Cambridge, MA) with a pore size of 0.4 
 
m
 
m and a diameter
of 6.5 mm, and maintained for 2 wk after being confluent. The samples
were fixed in 4% paraformaldehyde in PBS for 10 min at room tempera-
ture, rinsed with PBS for 10 min, and permeabilized with PBS containing
5% BSA and 0.02% saponin for 10 min. The fixed cells were incubated
with rabbit anti–AF-6 (1:100) in PBS containing 0.005% saponin or a hy-
bridoma culture medium containing mouse anti–ZO-1 antibody for 2 h,
followed by three washes with PBS containing 0.005% saponin for 20 min
in each step. The cells were incubated with an anti–rabbit antibody or an
anti–mouse antibody coupled with 1.4-nm gold particles (Nanoprobes, Inc.,
Stony Brook, NY) for 2 h, followed by three washes with PBS containing
0.005% saponin. For the double staining study, the samples were incu-
bated with a hybridoma culture medium containing mouse anti–ZO-1 anti- 
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body and 0.005% saponin for 2 h and washed three times with PBS
containing 0.005% saponin. The cells were then incubated with HRP-con-
jugated anti–mouse antibody (1:1,000; Jackson ImmunoResearch Lab.,
Inc., West Grove, PA) followed by three washes with PBS containing
0.005% saponin. The samples were incubated twice with 0.1 M PB (0.1 M
sodium phosphate buffer at pH 7.4) for 5 min, fixed with 0.1% glutaralde-
hyde in 0.1 M PB for 10 min, and rinsed with 0.1 M PB for 5 min. The sam-
ples were then incubated three times with 50 mM Hepes, at pH 5.8, for 10
min. The signals were silver enhanced with the use of HQ silver (Nano-
probes) for 8 min at 18
 
8
 
C in the dark, followed by three washes with 0.1 M
PB. The samples were incubated with a DAB solution (50 mM Hepes at
pH 7.4, 0.05% 3,3
 
9
 
-diaminobenzidine tetrahydrochloride) for 30 min and
then incubated with the DAB solution containing 0.01% H
 
2
 
O
 
2
 
 for 20 min.
The samples were postfixed with 0.5% OsO
 
4
 
 in 0.1 M PB for 60 min at
4
 
8
 
C, washed twice with 0.1 M PB for 5 min, dehydrated by passage through
a graded series of ethanol (50, 60, 70, 80, 90, 95, and 100%) and propylene
oxide, and then embedded in epoxy resin (Polysciences, Inc., Warrington,
PA). Ultrathin sections were cut, stained with lead citrate, and observed
with an immunoelectron microscope (JEM-1200; JEOL, Tokyo, Japan).
 
Immunocytochemistry of Mouse Intestinal Epithelium
 
Mice were anesthetized with halothane and fixed by transcardiac perfu-
sion with PBS containing 2% paraformaldehyde, 1 mM CaCl
 
2
 
 and 8% su-
crose. The intestine was removed, immersed in the same fixative, and cryo-
protected through a range of increasing sucrose concentrations (10, 15, 20,
and 25%) in 50 mM Tris-buffered saline. The intestine was embedded in
OCT compound, quick-frozen, and cut into 8-
 
m
 
m-thick sections in a cryo-
stat. The frozen sections, mounted on slides, were then washed with PBS,
fixed in 4% paraformaldehyde in PBS for 10 min, and permeabilized with
0.2% Triton X-100 in PBS for 10 min. The samples were subjected to im-
munostaining and examined as described above.
 
Affinity Column Chromatography
 
GST fusion proteins (each 6 nmol) were immobilized on 200 
 
m
 
l of glu-
tathione Sepharose 4B packed into columns. Bovine membrane fraction
or crude Sf-9 cell lysate expressing HA-AF-6 was loaded onto the affinity
columns. The columns were washed with 2 ml (10 vol) of buffer B (20 mM
Tris/HCl at pH 7.5, 1 mM EDTA, 1 mM DTT, 5 mM MgCl
 
2
 
, 10 
 
m
 
M
[
 
p
 
-amidino-phenyl] methanesulfonyl fluoride, 10 
 
m
 
g/ml leupeptin), fol-
lowed by washing with 2 ml (10 vol) buffer B containing 50 mM NaCl. The
proteins bound to the affinity columns were eluted three times by the ad-
dition of 660 
 
m
 
l (3.3 vol) of buffer B containing 10 mM reduced glu-
tathione. The eluates were subjected to SDS-PAGE and transferred to
PVDF membranes. The eluted native AF-6 and recombinant HA-AF-6
were immunodetected with the anti–AF-6 antibody.
 
In Vitro Binding Assay (In Vitro–Translated AF-6)
 
The in vitro translation of pRSET-AF-6 (36–494 amino acids), AF-6 (495–
909 amino acids), AF-6 (914–1,129 amino acids), and AF-6 (1,130–1,612
amino acids) were performed using the TNT T7-coupled reticulocyte ly-
sate system (Promega, Madison, WI) under the conditions described in the
manufacturer’s instruction manual. GST fusion proteins were immobi-
lized onto 31 
 
m
 
l of glutathione Sepharose 4B beads and washed with 310 
 
m
 
l
(10 vol) of buffer B. The immobilized beads were added to 40 
 
m
 
l of the in
vitro–translated products labeled with [
 
35
 
S]methionine containing 1 mg/ml
BSA and incubated for 1 h at 4
 
8
 
C with gentle mixing. The beads were
washed three times with 102 
 
m
 
l (3.3 vol) of buffer B, and the bound pro-
teins were eluted with GST fusion proteins three times by the addition of
102 
 
m
 
l (3.3 vol) of buffer B containing 10 mM reduced glutathione. The
eluates were subjected to SDS-PAGE and vacuum dried. The 
 
35
 
S-labeled
bands corresponding to in vitro–translated AF-6 were visualized with an
image analyzer (BAS-2000; Fuji, Tokyo, Japan).
 
In Vitro Binding Assay (MBP-AF-6)
 
The expression of maltose-binding protein (MBP)-AF-6 (36–206 amino
acids) in 
 
E. coli
 
 was performed as described previously (Kuriyama et al.,
1996). GST-ZO-1 (0.1 nmol) was immobilized on 100 
 
m
 
l of glutathione
Sepharose 4B packed into columns. 
 
E. coli
 
 BL21(DE3) producing MBP-
AF-6 (36–206 amino acids) was suspended in buffer A. The suspension
was sonicated and centrifuged at 100,000 
 
g
 
 for 60 min at 4
 
8
 
C. The superna-
tants containing various concentrations of MBP-AF-6 (36–206 amino ac-
ids) were then loaded onto the GST-ZO-1 columns. The columns were
washed with 1 ml (10 vol) of buffer B, followed by washing with 1 ml (10
vol) buffer B containing 50 mM NaCl. The proteins bound to GST-ZO-1
columns were eluted with GST-ZO-1 three times by the addition of 330 
 
m
 
l
(3.3 vol) of buffer B containing 10 mM reduced glutathione. The eluted
MBP-AF-6 was immunodetected with the anti-MBP antibody. The immu-
nodetected MBP-AF-6 was visualized and estimated with a densitograph
(ATTO, Tokyo, Japan).
 
Dissociation of AF-6 from ZO-1 by Activated Ras
 
GST-Ha-Ras and GST-Rac were produced in 
 
E. coli
 
 DH5
 
a
 
 and cleaved
with thrombin according to the manufacturer’s instructions. The guanine
nucleotide-bound forms of Ha-Ras and Rac were made by incubating
Ha-Ras or Rac (5 nmol) for 1 h at 30
 
8
 
C with 50 
 
m
 
M GDP or guanosine 5
 
9
 
-
(3-
 
O
 
-thio)-triphosphate (GTP
 
g
 
S) in 1 ml of a reaction mixture (20 mM
Tris/HCl at pH 7.5, 10 mM EDTA, 1 mM DTT, 5 mM MgCl
 
2
 
). The bind-
ing of MBP-AF-6 (36–206 amino acids) to GST-ZO-1 columns was carried
out as described above. The proteins bound to GST-ZO-1 columns were
eluted three times by the addition of 330 
 
m
 
l (3.3 vol) of 2 
 
m
 
M GDP/Ha-
Ras, GTP
 
g
 
S/Ha-Ras, or GTP
 
g
 
S/Rac. The eluted MBP-AF-6 was immu-
nodetected with the anti-MBP antibody.
 
Other Procedures
 
SDS-PAGE was performed as described (Laemmli, 1970). Protein con-
centrations were determined with BSA as the reference protein as de-
scribed (Bradford, 1976). Immunoblot analysis was carried out as de-
scribed (Harlow and Lane, 1988).
 
Results
 
Colocalization of AF-6 with ZO-1 But Not
with 
 
a
 
-Catenin
 
To clarify the functions of AF-6, we examined its intracel-
lular distribution in MDCKII epithelial cells. First, immu-
noblot analysis was performed on cell lysates from MDCKII
cells, using a polyclonal anti–AF-6 antibody. The anti–AF-6
antibody recognized two isoforms of AF-6 with molecular
masses of 
 
z
 
180 and 195 kD in the sample obtained from
MDCKII cells (Fig. 1) as described for bovine brain ex-
tract (Kuriyama et al., 1996). Preincubation of the anti-
body with the recombinant AF-6 abolished the immunore-
activity, indicating the expression of AF-6 in MDCKII
cells.
We then examined the AF-6 localization in confluent
MDCKII cells, which show characteristics of polarized epi-
thelial cells and form the junctional complex, including the
tight junctions and adherens junctions, at cell–cell contact
sites (Gonzalez-Mariscal et al., 1985). The immunoreactivity
of AF-6 was specifically localized at sites where a cell con-
tacted a neighbor cell, but not at the free ends, and showed
a belt-like pattern of staining along the cell–cell contact
sites (Fig. 2, 
 
a
 
 and 
 
d
 
). The cytosol exhibited a relatively
low level of the anti–AF-6 staining. To examine whether
AF-6 exists in the tight junctions or adherens junctions,
the cellular distribution of AF-6 was compared with those
of ZO-1 and 
 
a
 
-catenin, which are marker proteins of tight
junctions and adherens junctions, respectively, by laser
scanning confocal microscopy. Three-dimensional images
of confluent MDCKII cells, doubly stained with antibodies
against AF-6 and ZO-1 or 
 
a
 
-catenin, were generated from
serial optical sections obtained by laser scanning confocal
microscopy. En face views showed that the localization of
AF-6 overlapped with that of ZO-1 (Fig. 2, 
 
a–c
 
), but was
somewhat different from that of 
 
a
 
-catenin (Fig. 2, 
 
d–f
 
). To 
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confirm that AF-6 is localized at apical lateral membranes,
five serial optical sections (one section every 0.8 
 
m
 
m) were
shown for each staining (Fig. 2, 
 
g–j
 
). These images showed
that AF-6 and ZO-1 were concentrated at the apical sec-
tions, whereas 
 
a
 
-catenin was found at more basal sections.
When the three-dimensional images were rotated latitudi-
nally by 90
 
8
 
, the rotated images showed that AF-6 was
colocalized with ZO-1 at the apical cell borders but not
with 
 
a
 
-catenin (Fig. 2, 
 
k
 
 and 
 
l
 
). Thus, it is likely that AF-6
is colocalized with ZO-1 at the tight junctions rather than
adherens junctions of the confluent MDCKII cells.
 
Immunoelectron Microscopic Localization of AF-6 and 
ZO-1 in Confluent MDCKII Cells
 
The ultrastructural localization of AF-6 and that of ZO-1
in MDCKII cells was further analyzed by the pre-embed-
ding procedure. The gold signals immunoreactive for AF-6
were identified on the cytoplasmic surface of the plasma
membranes in the junctional complex region (Fig. 3 
 
a
 
). The
area immunoreactive for AF-6 was 400–500 nm long in
cross-section and usually started from the apical-most point
where the apical-adjacent plasma membranes converged
(Fig. 3 
 
a
 
). A few gold particles were noted along the lateral
plasma membranes outside the junctional complex region.
The gold signals for ZO-1 were also identified to be almost
exclusively concentrated on the cytoplasmic surface of the
plasma membranes in the junctional complex region (Fig.
3 
 
b
 
). The area immunoreactive for ZO-1 was 300–500 nm
long and always started from the apical-most point of the
junctional complex region. When this junctional complex
region was double labeled with anti–AF-6 polyclonal anti-
body and anti–ZO-1 monoclonal antibody, AF-6 immu-
noreactivity and that of ZO-1 was colocalized in the main
part of the junctional complex region (Fig. 3, 
 
c
 
 and 
 
d
 
). In
Fig. 3 
 
d
 
, a cross-section of a junctional complex is seen in
the center, and an oblique section of another junctional
complex is seen in the right side of the photograph. Taken
together, these results indicate that AF-6 is colocalized
with ZO-1 in the junctional complex.
 
Ca
 
2
 
1
 
-dependent Distribution of AF-6 and ZO-1 at
Cell–Cell Contact Sites of MDCKII Cells
 
We examined the localization of AF-6 in MDCKII cells dur-
ing the formation and disappearance of cell–cell contacts.
The formation of cell–cell contacts and the junctional
Figure 1. Immunoblot analysis of MDCKII, Rat1, and PC12 cell
lysates with anti–AF-6 antibody. Lane 1, MDCKII cell lysate with
preimmuneserum; lane 2, MDCKII cell lysate with anti–AF-6 anti-
body preincubated with recombinant AF-6; lane 3, MDCKII cell
lysate with anti–AF-6 antibody; lane 4, Rat1 cell lysate with anti–
AF-6 antibody; lane 5, PC12 cell lysate with anti–AF-6 antibody.
The results shown are representative of three independent exper-
iments. The arrowheads denote the position of AF-6.
Figure 2. Confocal microscope images of confluent MDCKII cells
showing the distributions of AF-6, ZO-1, and a-catenin. Conflu-
ent MDCKII cells were doubly stained with a rabbit polyclonal
antibody against AF-6 and a mouse monoclonal antibody against
ZO-1 (a–c, h, and k) or a rat monoclonal antibody against a-cate-
nin (d–f, j, and l), followed by FITC-conjugated anti–rabbit IgG
and Texas red-conjugated anti–mouse IgG or Texas red-conju-
gated anti–rat IgG antibodies. 20 serial optical sections were ob-
tained at 0.8-mm intervals, and three-dimensional images were
generated. In images a, c, d, f, k, and l, AF-6 is shown in green,
and ZO-1 (b, c, and k) or a-catenin (e, f, and l) is shown in red.
The yellow area indicates the colocalization of AF-6 and ZO-1 (c
and k) or a-catenin (f and l). Images a–f are unrotated en face
view. In images k and l, images c and f are rotated latitudinally by
908, respectively. Images g–j show five confocal sections for each
staining. Images g and i show the distribution of AF-6, and im-
ages h and j show that of ZO-1 and of a-catenin, respectively.
Subsequent sections from apical to basal were shown from left to
right. The results shown are representative of three independent
experiments. Bars, 10 mm.Yamamoto et al. Interaction of AF-6 with ZO-1 789
complex can be reversed by transferring cells between low
Ca21 and normal Ca21 media (Ca21 switch experiment).
When the MDCKII cells were cultured in low Ca21 media
for 6 h, cell–cell contacts were disrupted and the cells be-
came rounded up, as described previously (Fig. 4 d; Gonza-
lez-Mariscal et al., 1985). Under such conditions, AF-6 and
ZO-1 showed cytoplasmic staining without specific local-
ization at the cell surface (Fig. 4, e and f). When the cells
were transferred to normal media, they formed cell–cell
contacts (Fig. 4 g), and AF-6 and ZO-1 had similar distri-
butions at the cell–cell contact sites (Fig. 4, h and i), sug-
gesting that AF-6 and ZO-1 show similar dynamic behav-
ior  during the formation and disappearance of cell–cell
contacts.
Localization of AF-6 in Mouse Intestinal
Epithelial Cells
Because intestinal epithelial cells have tight junctions at
the apical cell borders, we examined the distribution of AF-6
in intestinal epithelial cells. Cryosections of mouse intes-
tine were double labeled with AF-6 and ZO-1 antibodies
and examined by laser scanning confocal microscopy. AF-6
and ZO-1 were colocalized at the apical cell borders (Fig.
5). These results indicate that AF-6 is colocalized with
ZO-1 at tight junctions of intestinal epithelial cells.
Localization of AF-6 in Cells Lacking Tight Junctions
In cells lacking tight junctions such as nonepithelial cells,
ZO-1 accumulates at cell–cell contact sites with cadherin
(Howarth et al., 1992; Itoh et al., 1993). A recent study
showed that ZO-1 interacts with catenins during the early
stages of the assembly of tight junctions (Rajasekaran et al.,
1996). We examined whether AF-6 accumulates at cell–
cell contact sites in cells lacking tight junctions such as
Rat1 fibroblasts and PC12 rat pheochromocytoma cells.
First, immunoblot analysis was performed on cell lysates
from Rat1 and PC12 cells. The anti–AF-6 antibody recog-
nized two bands in the samples from Rat1 and PC12 cells
as described for MDCKII cells (Fig. 1). We next examined
the distribution of AF-6 in Rat1 and PC12 cells. AF-6 ac-
cumulated at the cell–cell contact sites and was colocalized
with ZO-1 in both the Rat1 fibroblasts and the PC12 rat
pheochromocytoma cells (Fig. 6). In the Rat1 fibroblasts,
the accumulation of AF-6 was discontinuous rather than a
belt-like accumulation as observed in the MDCKII epithe-
lial cells. These results indicate that AF-6 is colocalized
with ZO-1 in cell–cell contact sites of cells lacking tight
junctions.
Figure 3. The ultrastructural localization of AF-6 and that of
ZO-1 in confluent MDCKII cells. Immunoelectron micrographs
of the junctional complex region in MDCKII cells stained with a
rabbit polyclonal antibody against AF-6 (a), with a mouse mono-
clonal antibody against ZO-1 (b), or doubly stained with both
anti–AF-6 polyclonal antibody (gold particles) and anti–ZO-1
monoclonal antibody (HRP reaction products; c and d). (a) The
gold particles for AF-6 are accumulated on the cytoplasmic sur-
face of the plasma membranes in the junctional complex region.
(b) ZO-1 labeling is exclusively concentrated in the junctional
complex region. (c and d) AF-6 immunoreactivity (gold particles)
and ZO-1 immunoreactivity (HRP reaction products) are inter-
mixed. The results shown are representative of three indepen-
dent experiments. Bar, 500 nm.
Figure 4. Immunofluorescence localization of AF-6 and that of
ZO-1 in Ca21 switch experiments with MDCKII cells. Subconflu-
ent MDCKII cells were grown in normal growth media (a–c) and
transferred to low Ca21 media (growth media containing 4 mM
EGTA) for 6 h (d–f) and then transferred back to the normal
Ca21 medium for 2 h (g–i). The cells were doubly stained with a
rabbit polyclonal antibody against AF-6 (b, e, and h) and a mouse
monoclonal antibody against ZO-1 (c, f, and i), followed by
FITC-conjugated anti–rabbit IgG and Texas red-conjugated anti–
mouse IgG antibodies, and examined using laser scanning confo-
cal microscopy. Images a, d, and g are phase contrast images. The
results shown are representative of three independent experi-
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Interaction of Bovine AF-6 with ZO-1 and Occludin
To examine the complex formation of AF-6 with tight junc-
tion components including ZO-1 and occludin, bovine brain
membrane fraction was loaded onto the affinity columns
immobilized with GST, GST-ZO-1, GST-occludin, GST–
E-cadherin, GST–a-catenin, GST–b-catenin, and GST-CD44.
The proteins bound to the affinity columns were eluted
with the GST fusion proteins by the addition of gluta-
thione, and the eluted AF-6 was detected with an anti–AF-6
antibody. AF-6 was detected in the eluate of the GST-ZO-1
affinity column and weakly in that of the GST-occludin af-
finity column, but not in those of the GST, GST–E-cadherin,
GST–a-catenin, GST–b-catenin, or GST-CD44 affinity col-
umns (Fig. 7). These results indicate that native AF-6 di-
rectly or indirectly interacts with ZO-1 and occludin.
Interaction of Recombinant AF-6 with ZO-1
To determine whether recombinant AF-6 interacts with
ZO-1 and occludin, crude lysates of Sf-9 cells infected with
baculovirus carrying the cDNA of HA-AF-6 (36–1,608
amino acids) were loaded onto the GST, GST-ZO-1, GST-
occludin, and GST-CD44 affinity columns. The proteins
bound to the affinity columns were eluted with GST fusion
proteins by the addition of glutathione, and the eluted
HA-AF-6 was detected with the anti–AF-6 antibody. HA-
AF-6 was detected in the eluate of the GST-ZO-1 affinity
column and weakly in that of GST-occludin affinity col-
umn, but not in those of the GST or GST-CD44 affinity
columns (Fig. 8). These results indicate that recombinant
AF-6 interacts with ZO-1. The reason for the weak inter-
action of recombinant AF-6 and occludin is not clear at
present. The recombinant AF-6 produced from Sf-9 cells
may have a lower affinity for occludin than that of native
AF-6, or the interaction of AF-6 and occludin is indirect
and this interaction may be mediated by ZO-1. When the
same samples were examined with HA antibody, smaller
size bands were detected in addition to full size AF-6 in
the eluate of the GST-ZO-1 affinity column (data not
shown). Since the AF-6 used in this experiment was tagged
with HA in its NH2 terminus, these smaller bands are
thought to represent the products degraded from the
Figure 5. Immunofluorescence localization of AF-6 and that of
ZO-1 in the frozen mouse intestinal epithelium. Cryosections of
mouse intestine were doubly stained with a rabbit polyclonal an-
tibody against AF-6 (a) and a mouse monoclonal antibody against
ZO-1 (b), followed by FITC-conjugated anti–rabbit IgG and Texas
red-conjugated anti–mouse IgG antibodies, and examined using
laser scanning confocal microscopy. The results shown are repre-
sentative of three independent experiments. Bar, 5 mm.
Figure 6. Colocalization of AF-6 with ZO-1 in Rat1 and PC12
cells. Subconfluent Rat1 (a–c) and PC12 (d–f) cells were doubly
stained with a rabbit polyclonal antibody against AF-6 (a, c, d,
and f) and a mouse monoclonal antibody against ZO-1 (b, c, e,
and f), followed by FITC-conjugated anti–rabbit IgG and Texas
red-conjugated anti–mouse IgG antibodies, and examined using
laser scanning confocal microscopy. AF-6 is shown in green (a, c,
d, and f) and ZO-1 (b, c, e, and f) is shown in red. In images c and
f, the yellow area indicates the colocalization of AF-6 and ZO-1.
The results shown are representative of three independent exper-
iments. Bars: (a–c) 10 mm; (d–f) 5 mm.
Figure 7. Interaction of bovine AF-6 with ZO-1. Bovine brain
membrane fraction was loaded onto affinity columns immobilized
with GST (lane 1), GST-ZO-1 (lane 2), GST-occludin (lane 3),
GST–E-cadherin (lane 4), GST–a-catenin (lane 5), GST–b-cate-
nin (lane 6), and GST-CD44 (lane 7). The interacting proteins
were eluted with GST proteins by the addition of glutathione.
The eluates were subjected to SDS-PAGE, followed by immuno-
blot analysis with anti–AF-6 antibody. The arrowheads denote
the position of bovine AF-6. The results shown are representative
of three independent experiments.
Figure 8. Interaction of re-
combinant AF-6 with ZO-1.
Crude lysates of Sf-9 cells in-
fected with baculovirus car-
rying HA-AF-6 cDNA were
loaded onto affinity columns
immobilized with GST (lane
1), GST-ZO-1 (lane 2), GST-occludin (lane 3), and GST-CD44
(lane 4). The interacting proteins were eluted with GST fusion
proteins by the addition of glutathione. The eluates were sub-
jected to SDS-PAGE and followed by immunoblot analysis with
anti–AF-6 antibody. The arrowheads denote the positions of
HA-AF-6. The results shown are representative of three inde-
pendent experiments.Yamamoto et al. Interaction of AF-6 with ZO-1 791
COOH terminus. Since the size of the major smaller band
was z50 kD, the interacting region of AF-6 with ZO-1
may contain the Ras-binding domain, which is identified
as 36–206 amino acids (Kuriyama et al., 1996).
We further examined which domain of AF-6 interacts
with ZO-1, using in vitro–translated AF-6 such as AF-6
(36–494 amino acids), AF-6 (495–909 amino acids), AF-6
(914–1,129 amino acids), and AF-6 (1,130–1,612 amino ac-
ids) (Fig. 9 a). Affinity beads immobilized with GST-ZO-1
were mixed with the in vitro–translated AF-6 (36–494
amino acids), AF-6 (495–909 amino acids), AF-6 (914–1,129
amino acids), and AF-6 (1,130–1,612 amino acids), and the
interacting proteins were then eluted with GST-ZO-1 by
the addition of glutathione. As shown in Fig. 9, b–e, AF-6
(36–494 amino acids) bound to GST-ZO-1 and weakly to
GST-occludin, but not to GST or GST-CD44, whereas the
other domains slightly bound to GST-ZO-1 and not to GST,
GST-occludin, or GST-CD44. These results together with
the above observations indicate that mainly the NH2-ter-
minal domain of AF-6 is responsible for the binding of AF-6
to ZO-1.
Dissociation of AF-6 from ZO-1 by Activated Ras
Since the Ras-binding domain and ZO-1–binding domain
are very close as noted above, we speculated that activated
Ras inhibited the interaction of AF-6 and ZO-1. To test
this possibility we first examined whether ZO-1 could bind
to MBP-AF-6 (36–206 amino acids), which binds to acti-
vated Ras as previously described (Kuriyama et al., 1996).
E. coli lysate containing MBP-AF-6 (36–206 amino acids)
was loaded onto affinity columns immobilized with GST,
GST-ZO-1, GDP/GST-Ha-Ras, GTPgS/GST-Ha-Ras, and
GST-CD44. The proteins bound to the affinity columns
were then eluted with the GST fusion proteins by the addi-
tion of glutathione, and the eluted MBP-AF-6 (36–206 amino
acids) was detected with an anti-MBP antibody. MBP-AF-6
(36–206 amino acids) was detected in the eluates of the
GST-ZO-1 or GTPgS/GST-Ha-Ras affinity columns, but
only slightly in those of the GST, GDP/GST-Ha-Ras, or
GST-CD44 affinity columns (Fig. 10 a). The weak binding
of MBP-AF-6 (36–206 amino acids) to GST, GDP/GST-
Ha-Ras, or GST-CD44 affinity columns appears to be back-
ground. Similar observations were obtained when MBP-
AF-6 (36–494 amino acids) was used instead of MBP-AF-6
(36–206 amino acids; data not shown). To assure the speci-
ficity of the binding, we carried out the kinetic study on
the binding of AF-6 to ZO-1. As shown in Fig. 10 b, MBP-
AF-6 (36–206 amino acids) bound to GST-ZO-1 in a dose-
dependent manner, and this binding was saturable when
the amounts of MBP-AF-6 (36–206 amino acids) were in-
creased. The apparent Kd value for the binding of MBP-
AF-6 (36–206 amino acids) to GST-ZO-1 was estimated
to be z260 nM under the conditions. Next, to examine
whether activated Ras dissociates AF-6 from ZO-1, we ap-
plied GTPgS/Ras onto a GST-ZO-1 column, which retained
MBP-AF-6 (36–206 amino acids). As shown in Fig. 10 c,
the bound MBP-AF-6 (36–206 amino acids) was eluted
with GTPgS/Ras, but was weakly eluted with GDP alone,
GTPgS alone, GDP/Ras, or GTPgS/Rac. It may be noted
that two bands corresponding to MBP-AF-6 were eluted
from the GST-ZO-1 or GTPgS/Ras affinity columns by
the addition of glutathione, whereas the upper band was
eluted more efficiently than the lower band by the addition
of GTPgS/Ras. The smaller size of MBP-AF-6 was proba-
bly the degradation product. We can not give the precise
reasons for this complexity, but it is probable that the
smaller size of MBP-AF-6 binds strongly to ZO-1 and
Figure 9. Interaction of in vitro–translated AF-6 (36–494 amino
acids) with ZO-1. (a) Domain diagram of AF-6 and the recombi-
nant fragments used for the in vitro binding assay. RB, Ras-bind-
ing domain; Myosin V, Myosin V–like domain; PDZ, PDZ do-
main. Bold lines show the recombinant fragments used for the in
vitro binding assay. (b–e) In vitro–translated AF-6 (36–494 amino
acids; b), AF-6 (495–909 amino acids; c), AF-6 (914–1,129 amino
acids; d), and AF-6 (1,130–1,612 amino acids; e) were mixed with
GST (lane 1), GST-ZO-1 (lane 2), GST-occludin (lane 3), and
GST-CD44 (lane 4) immobilized to glutathione Sepharose 4B
beads. The interacting proteins were eluted with GST fusion pro-
teins by the addition of glutathione. The eluates were subjected
to SDS-PAGE and vacuum dried. The in vitro–translated AF-6
fragments were visualized with an image analyzer. The arrowheads
denote the position of in vitro–translated AF-6 fragments. The
results shown are representative of three independent experiments.The Journal of Cell Biology, Volume 139, 1997 792
hardly dissociates from ZO-1 by the addition of GTPgS/
Ras. Taken together, these results indicate that ZO-1 in-
teracts with the Ras-binding domain of AF-6 (36–206
amino acids) and that this interaction may be inhibited
specifically by activated Ras.
Localization of AF-6 in Activated Ras-expressing Rat1 
Fibroblast Cells
As previously described, some ras-transformed fibroblast
cells display anchorage-independent growth and reduced
cell–cell contacts. We examined the localization of AF-6 in
activated Ras-expressing Rat1 fibroblast cells. For this pur-
pose, we used a Rat1 cell line that contains the activated
ras (rasV12) gene under Lac repressor control, designated
as Rat1 RasVal A1 cells. The addition of IPTG efficiently
induced the expression of RasV12 (Fig. 11 A). The distribu-
tions of AF-6 and ZO-1 were examined as described above.
In the Rat1 RasVal A1 cells in the absence of IPTG, AF-6
accumulated at cell–cell contact sites and was colocalized
with ZO-1, as seen in the wild-type strain of Rat1 cells (Fig.
11, B, c and d). When Rat1 RasVal A1 cells were treated
with IPTG, their morphology changed dynamically and
the cell–cell contacts were perturbed. In these cells, the
colocalization of AF-6 and ZO-1 was decreased at the sur-
face of the cells dissociated from neighbor cells (Fig. 11, B,
e and f). These results suggest that AF-6 may contribute to
the perturbation of cell–cell contacts by activated Ras, or
that the altered cell–cell contacts by activated Ras may
change the cellular distribution of AF-6.
Discussion
AF-6 Is a Peripheral Component of Junctional Complex
Our immunofluorescent and immunoelectron microscopic
analysis showed that AF-6 is concentrated at tight junc-
tions in confluent MDCKII cells, and that its distribution
closely overlaps with that of ZO-1. Native and recombi-
nant AF-6 interacts with ZO-1 in vitro. ZO-1 is thought to
directly interact with occludin and to serve as an essential
peripheral component of tight junctions (Furuse et al.,
1994). Thus, these results indicate that AF-6 is a periph-
eral component of tight junctions. Although the roles of
AF-6 in tight junctions are not clear, it is possible that AF-6
modulates the functions of ZO-1 downstream of Ras. We
have also found that AF-6 from bovine brain interacts
with the GST-occludin affinity beads, whereas the purified
AF-6 from insect cells, which lack ZO-1, only weakly in-
teracts with the same beads. This raises the possibility that
the binding of AF-6 from bovine brain may be mainly me-
diated by ZO-1.
A recent study showed that ZO-1 interacts with catenins
during the early stages of the assembly of tight junctions
(Rajasekaran et al., 1996). In cells lacking tight junctions
such as fibroblasts and astrocytes, ZO-1 is localized at
cell–cell contact sites with cadherin (Howarth et al., 1992;
Itoh et al., 1993). We found here that AF-6 is localized with
ZO-1 at cell–cell contact sites in Rat1 fibroblasts and PC12
rat pheochromocytoma cells lacking tight junctions. These
results suggest that AF-6 is recruited with ZO-1 at cell–cell
contact sites, where cadherin is localized, and serves as a
peripheral component of cell–cell adhesions in cells lack-
ing tight junctions.
ZO-1–binding Domain of AF-6
Since it has been reported that some PDZ domains can
bind to other PDZ domains (Brenman et al., 1996), we first
Figure 10. Dissociation of the Ras-interacting domain of AF-6
from ZO-1 by activated Ras. (a) Interaction of MBP-AF-6 (36–
206 amino acids) with ZO-1. Crude lysates of E. coli expressing
MBP-AF-6 (36–206 amino acids) were loaded onto affinity col-
umns immobilized with GST (lane 1), GST-ZO-1 (lane 2), GDP/
GST–Ha-Ras (lane 3), GTPgS/GST–Ha-Ras (lane 4), and GST-
CD44 (lane 5). The interacting proteins were eluted with GST fusion
proteins by the addition of glutathione. The eluates were sub-
jected to SDS-PAGE and followed by immunoblot analysis with
anti-MBP antibody. The arrowheads denote the positions of MBP-
AF-6 (36–206 amino acids). (b) The kinetic study on the binding
of MBP-AF-6 (36–206 amino acids) to GST-ZO-1. E. coli lysates
containing various concentrations of MBP-AF-6 (36–206 amino
acids) were loaded onto the GST-ZO-1 and GST-CD44 affinity
columns (0.1 nmol). The proteins bound to GST-ZO-1 columns
were eluted with GST-ZO-1 by the addition of glutathione. The
eluates were subjected to SDS-PAGE and followed by immuno-
blot analysis with anti-MBP antibody. The immunodetected
MBP-AF-6 were visualized and estimated with a densitograph.
The values shown are means 6 SEM of triplicate experiments. j,
with GST-ZO-1; m, with GST-CD44. (c) Dissociation of MBP-
AF-6 (36–206 amino acids) from ZO-1 by activated Ras. Crude ly-
sates of E. coli expressing MBP-AF-6 (36–206 amino acids) were
loaded onto affinity columns immobilized with GST-ZO-1. The
proteins bound to the GST-ZO-1 columns were eluted by the ad-
dition of buffer containing GDP alone (lane 1), GTPgS alone
(lane 2), GDP/Ras (lane 3), GTPgS/Ras (lane 4), and GTPgS/Rac
(lane 5). The eluates were subjected to SDS-PAGE and followed
by immunoblot analysis with anti-MBP antibody. The arrowhead
denotes the position of MBP-AF-6 (36–206 amino acids). The re-
sults shown are representative of three independent experiments.Yamamoto et al. Interaction of AF-6 with ZO-1 793
thought that the PDZ domain of AF-6 may interact with
the PDZ domain of ZO-1. The present results, however,
indicate that the NH2-terminal domain (36–206 amino ac-
ids) of AF-6 is mainly responsible for the interaction with
ZO-1. A previous study showed that the NH2-terminal do-
main (36–206 amino acids) binds to activated Ras (Kuri-
yama et al., 1996). The present findings indicate that the
Ras-binding domain and ZO-1–binding domain of AF-6
are very close or overlapped, though the ZO-1–binding
domain of AF-6 is not necessarily coincident with the Ras-
binding domain.
The GST-ZO-1 used in this study contains three PDZ
domains, an SH3 domain, and a guanylate kinase domain.
It is possible that the SH3 domain of ZO-1 interacts with
the proline-rich domain of AF-6. Indeed, our in vitro bind-
ing assay showed that AF-6 (1,130–1,612 amino acids) in-
teracts with ZO-1, but this interaction is weaker than that
of AF-6 (36–494 amino acids). The AF-6–binding domain
of ZO-1 remains to be identified. The interaction of re-
combinant AF-6 with occludin is very weak. It remains to
be clarified whether AF-6 directly interacts with occludin
in vivo.
Possible Roles of AF-6 in the Regulation of
Cell–Cell Contacts
AF-6 is composed of several domains including Ras-bind-
ing, ZO-1–binding, myosin V-like, PDZ, and the COOH-
terminal domains. Although the roles of AF-6 in the regu-
lation of cell–cell contacts remain to be clarified, AF-6 may
be a scaffolding protein as a peripheral component at the
cell–cell contact sites. AF-6 shows the strong sequence ho-
mology with Drosophila Canoe and shares a common do-
main organization with Canoe (Kuriyama et al., 1996). Ca-
noe is implicated in the formation of cone cells in the
developing compound eye in Drosophila (Matsuo et al.,
1997). The fates of cone cells are thought to be determined
by cell–cell contacts. The phenotypic effect of canoe muta-
tions on the cone cells depends on the state of Ras (Mat-
suo et al., 1997), and Canoe is shown to interact with the
activated Ras in a cell-free system, indicating that Canoe
serves as a target of Ras as described for AF-6 (Kuriyama
et al., 1996). Genetic study of Canoe in Drosophila will
provide us further information on the roles of Canoe/AF-6
in the regulation of cell–cell contacts.
We have shown here that AF-6 can interact with ZO-1
in vitro and is colocalized with ZO-1 at cell–cell contact
sites including tight junctions. This suggests that AF-6 can
modulate the function of ZO-1. ZO-1 is thought to be a
linkage molecule between occludin and actin cytoskeleton
and to play important roles in the rearrangement of cell–
cell contacts and cytoskeletons (Furuse et al., 1994). It is
possible that AF-6 modulates the function of ZO-1 and
subsequently regulates the cell–cell contacts.
We have recently found that AF-6 interacts with fila-
mentous actin by a cosedimentation assay (data not shown).
Actin cytoskeleton is known to be linked to adhesion mol-
ecules through certain peripheral components and to sup-
port the cell–cell adhesions. Although the mode of interac-
tion between AF-6 and filamentous actin is not known at
present, the actin-binding activity of AF-6 may be neces-
sary for the regulation of the cell–cell adhesions through
Figure 11. Localization of AF-6 in Ras-transformed Rat1 cells.
(A) Immunoblot analysis of Rat1 RasVal A1 cells. The expres-
sion of RasV12 was induced in Rat1 RasVal A1 cells (lanes 3) by
the addition of IPTG, and the cell lysates were subjected to SDS-
PAGE, followed by immunoblot analysis with anti-Ras antibody
(Rask4). Lane 1, Wild-type Rat1 cells; lane 2, Rat1 RasVal A1
cells in the absence of IPTG; lane 3, Rat1 RasVal A1 cells treated
with IPTG for 24 h. (B) Localization of AF-6 in Ras-transformed
Rat1 cells. Wild-type Rat1 cells (a and b), Rat1 RasVal A1 cells in
the absence of IPTG (c and d), and Rat1 RasVal A1 cells treated
with 5 mM IPTG for 24 h (e and f) were doubly stained with a
rabbit polyclonal antibody against AF-6 (a, c, and e) and a mouse
monoclonal antibody against ZO-1 (b, d, and f), followed by
FITC-conjugated anti–rabbit IgG and Texas red-conjugated anti–
mouse IgG antibodies. The results shown are representative of
three independent experiments. Bar, 10 mm.The Journal of Cell Biology, Volume 139, 1997 794
AF-6. The COOH-terminal domain of AF-6 has the pro-
line-rich region, which is thought to interact with certain
proteins containing the SH3 or WW domain (Sudol, 1996).
Searching for interacting proteins with the COOH-termi-
nal domain is under investigation to understand the func-
tions of AF-6.
Regulation of the Interaction of AF-6 and ZO-1 by 
Activated Ras
As described above, it is likely that the Ras-binding do-
main and ZO-1–binding domain of AF-6 are quite close.
This led us to examine whether Ras inhibits the interac-
tion of AF-6 with ZO-1. Indeed, activated Ras can dissoci-
ate MBP-AF-6 (36–206 amino acids) from ZO-1. This sug-
gests that activated Ras inhibits the interaction of AF-6
and ZO-1 at cell–cell adhesions. Our preliminary experi-
ments, however, showed that activated Ras dissociates full
length recombinant AF-6 from ZO-1 less efficiently than
MBP-AF-6 (36–206 amino acids) from ZO-1 (data not
shown). The reason for the less efficient dissociation of full
length AF-6 from ZO-1 is not known. Another domain of
AF-6 in addition to the NH2-terminal domain containing
the Ras-binding domain may strengthen the interaction of
AF-6 and ZO-1. Alternatively, activated Ras may change
the state of the AF-6–ZO-1 complex without dissociating
AF-6 from ZO-1. In addition, since we used the recombi-
nant Ras produced from bacteria, which was not modified
with lipid at the COOH terminus, it is possible that lipid-
modified, activated Ras can efficiently dissociate full length
AF-6 from ZO-1.
Regulation of Cell–Cell Contacts by Ras
Ras is thought to regulate the dynamics of cell–cell con-
tacts. Some ras-transformed epithelial cells display a fibro-
blastic morphology and reduced cell–cell contacts, as pre-
viously described (Basolo et al., 1991; Kinch et al., 1995).
Several molecules interacting with activated Ras in addi-
tion to AF-6 have been identified as Ras targets in mam-
mals. These include Raf (Daum et al., 1994), phosphati-
dylinositol-3-OH kinase (Rodriguez-Viciana et al., 1994),
Ral guanine nucleotide dissociation stimulator (Kikuchi
et al., 1994; Spaargaren and Bischoff, 1994), and Rin1 (Han
and Colicelli, 1995). One of these Ras targets may account
for the functions of Ras in the regulation of cell–cell con-
tacts. We have shown here that AF-6 specifically accumu-
lates at cell–cell contact sites. None of the above Ras tar-
gets except for AF-6 is reported to accumulate at cell–cell
contact sites in an adhesion-dependent fashion. Expres-
sion of activated Ras perturbs cell–cell contacts in Rat1 fi-
broblast cells, followed by a decrease in the accumulation
of AF-6 and ZO-1 at the cell surface. Moreover, we have
shown here that AF-6 interacts with ZO-1, and this inter-
action is inhibited by activated Ras. Taken together, it is
likely that the Ras-AF-6 pathway plays critical roles in the
regulation of the cell–cell contacts through ZO-1. Alterna-
tively, the altered cell–cell contacts by activated Ras may
change the cellular distribution of AF-6 and ZO-1. The ac-
tivated Ras-expressing cells change a plethora of charac-
teristics. We do not know exactly what happens in these
cells. Further studies are necessary for better understand-
ing the mechanism of the regulation of cell–cell contacts
by Ras.
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